Annals of Saudi medicine
-
Annals of Saudi medicine · May 2022
Clinical outcomes of patients with COVID-19 and inflammatory rheumatic diseases receiving biological/targeted therapy.
Anti-cytokine treatments are used in the treatment of severe COVID-19. Other studies have shown statistical significance with TNF inhibitors but not with other biological/targeted synthetic disease-modifying anti-rheumatic drugs (b/tsDMARD). ⋯ None.
-
Annals of Saudi medicine · May 2022
Sinovac vaccination and the course of COVID-19 disease in hospitalized patients in Turkey.
The Alpha variant of SARS-CoV-2 has a higher transmission rate than the first variant identified. The efficacy of vaccines is affected by the characteristics of SARS-CoV-2 variants. ⋯ None.
-
Annals of Saudi medicine · May 2022
Prognosis of gastric adenocarcinoma associated with girdin, Akt, and cortactin.
The actin-binding protein girdin regulates tumor cell migration and invasion by maintaining actin structure. PI3K/Akt signaling is an important actin-remodeling pathway. The protein cortactin acts directly on microfilaments and promotes tumor invasion and metastasis by rearranging the cytoskeleton. However, there are few reports on the co-expression of girdin, Akt, and cortactin in gastric adenocarcinoma (GAC). ⋯ None.
-
Annals of Saudi medicine · Mar 2022
Diabetic ketoacidosis in Saudi Arabia: factors precipitating initial admission and readmission.
Diabetic ketoacidosis (DKA) is one of the complications of diabetes mellitus (DM), primarily type 1 DM. To our knowledge, only one study explored DKA readmission rates in Saudi Arabia. ⋯ None.
-
Annals of Saudi medicine · Mar 2022
Cut-off values in newborn screening for inborn errors of metabolism in Saudi Arabia.
Newborn screening identifies individuals affected by a specific disorder within an apparently healthy population prior to the appearance of symptoms so that appropriate interventions can be initiated in time to minimize the harmful effects. Data on population based cut-off values, disease ranges for true positive cases, false positive rates, true positive rates, cut-off verification and comparisons with international cut-off ranges have not been done for Saudi Arabia. ⋯ None.